Literature DB >> 8949984

Effects of modulators of multidrug resistance on the expression of the MDR1 gene on human KB cells in culture.

Y P Hu1, P Pourquier, F Doignon, M Crouzet, J Robert.   

Abstract

The effect of four modulators of multidrug resistance (MDR) on the expression of the MDR1 gene was studied in two resistant variants of the KB cell lines, KB V1 and KB A1. This was done using a semi-quantitative assay based on mRNA reverse transcription coupled with polymerase chain reaction of the cDNA obtained. An automatic DNA sequencer was used for the measurement of the fluorescent amplification products and the MDR1 signal was compared to that of the beta-actin gene of the cells. After 24 h incubation with 15 microM of the modulators, MDR1 gene expression was slightly but significantly decreased by two of them, quinine and cyclosporine A, whereas verapamil and S-9788 had very little effect on this parameter. The effect were more pronounced in the KB A1 line than in the KB V1 line. The effect of quinine was studied over a longer time period (4-48 h) and was shown to be maximum at 24 h. These results favor the existence of a direct effect of some MDR reverters, especially quinine, on the expression of the MDR1 gene and could partially explain their modulating effect of MDR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949984     DOI: 10.1097/00001813-199609000-00004

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

1.  Effect of BIBF 1120 on reversal of ABCB1-mediated multidrug resistance.

Authors:  Qing-feng Xiang; Fang Wang; Xiao-dong Su; Yong-ju Liang; Li-sheng Zheng; Yan-jun Mi; Wei-qiang Chen; Li-wu Fu
Journal:  Cell Oncol (Dordr)       Date:  2011-01-28       Impact factor: 6.730

2.  Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids.

Authors:  Pornngarm Limtrakul; Songyot Anuchapreeda; Duang Buddhasukh
Journal:  BMC Cancer       Date:  2004-04-17       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.